FibroBiologics, Inc.
FBLG
$0.5998
-$0.0052-0.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 48.08% | 6.24% | 52.62% | -27.30% | -47.50% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 157.34% | -13.94% | 525.00% | 1,207.41% | 661.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 0.00% | 12.50% | -85.12% | -94.27% |
| Total Current Assets | 56.37% | 4.54% | 54.40% | -24.89% | -44.65% |
|
|
|||||
| Total Current Assets | 56.37% | 4.54% | 54.40% | -24.89% | -44.65% |
| Net Property, Plant & Equipment | 53.18% | -15.26% | -14.93% | -4.78% | 15.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 56.05% | 0.24% | 39.12% | -21.28% | -35.63% |
|
|
|||||
| Total Accounts Payable | 49.09% | 74.08% | 86.77% | 43.78% | 102.01% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 2,710.45% | 1,172.11% | -- | -18.44% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 64.14% | 10.75% | 10.77% | 11.05% | 11.05% |
| Total Finance Division Other Current Liabilities | -94.31% | -95.60% | -93.76% | -- | -- |
| Total Other Current Liabilities | -94.31% | -95.60% | -93.76% | -- | -- |
| Total Current Liabilities | 8.21% | -41.29% | 38.58% | 408.14% | 975.58% |
|
|
|||||
| Total Current Liabilities | 8.21% | -41.29% | 38.58% | 408.14% | 975.58% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 2,710.45% | 1,172.11% | -- | -18.44% | -- |
| Capital Leases | 78.49% | -32.26% | -28.95% | -27.09% | -24.66% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.47% | -40.53% | 29.73% | 180.04% | 353.59% |
|
|
|||||
| Common Stock & APIC | 55.77% | 47.94% | 49.37% | 39.63% | 24.08% |
| Retained Earnings | -41.43% | -23.36% | -45.82% | -121.44% | -156.42% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 136.03% | 160.83% | 118.28% | -74.03% | -121.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 136.03% | 160.83% | 118.28% | -74.03% | -121.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 136.03% | 160.83% | 118.28% | -74.03% | -121.03% |
|
|
|||||